Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (51-60 of 251) with videos related to

Pageof 26
Sort By:
Mutation Research|September 1, 1995
DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitorsY Pommier, J Jenkins, G Kohlhagen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1980
Effects of some alpha-adrenoceptor agonists and antagonists on the guinea-pig ileumM Andréjak, Y Pommier, P Mouillé, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of HIV integrase by novel nucleotides bearing tricyclic basesJ Zhang, N Neamati, Y Pommier, et al.
Biochimica Et Biophysica Acta|September 28, 1998
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzymeY Pommier, P Pourquier, Y Fan, et al.
Oncogene|February 14, 2007
Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288)L-H Meng, K W Kohn, Y Pommier
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2000
Analysis of cleavage complexes using reactive inhibitor derivativesK N Kreuzer, C H Freudenreich, Y Pommier
Molecular Pharmacology|December 1, 1996
Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repairA Fujimori, M Gupta, Y Hoki, et al.
Biochemical and Biophysical Research Communications|December 30, 1994
DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter regionY Pommier, B Poddevin, M Gupta, et al.
Experimental Cell Research|August 1, 1993
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitorsR Bertrand, E Solary, J Jenkins, et al.
Journal of the National Cancer Institute|June 1, 1994
Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trialsA Tanizawa, A Fujimori, Y Fujimori, et al.
Pageof 26

Showing results (51-60 of 251) with videos related to

Sort By:
Pageof 26
Mutation Research|September 1, 1995
DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitorsY Pommier, J Jenkins, G Kohlhagen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1980
Effects of some alpha-adrenoceptor agonists and antagonists on the guinea-pig ileumM Andréjak, Y Pommier, P Mouillé, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of HIV integrase by novel nucleotides bearing tricyclic basesJ Zhang, N Neamati, Y Pommier, et al.
Biochimica Et Biophysica Acta|September 28, 1998
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzymeY Pommier, P Pourquier, Y Fan, et al.
Oncogene|February 14, 2007
Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288)L-H Meng, K W Kohn, Y Pommier
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2000
Analysis of cleavage complexes using reactive inhibitor derivativesK N Kreuzer, C H Freudenreich, Y Pommier
Molecular Pharmacology|December 1, 1996
Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repairA Fujimori, M Gupta, Y Hoki, et al.
Biochemical and Biophysical Research Communications|December 30, 1994
DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter regionY Pommier, B Poddevin, M Gupta, et al.
Experimental Cell Research|August 1, 1993
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitorsR Bertrand, E Solary, J Jenkins, et al.
Journal of the National Cancer Institute|June 1, 1994
Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trialsA Tanizawa, A Fujimori, Y Fujimori, et al.
Pageof 26